- Formula
- Estriol 0.3% / vitamin C 5% / hydrolyzed hyaluronic acid 0.5%
- Starting price
- $48/month
- Status
- Compounded prescription
Three named components, three different roles
Time Out combines a hormone ingredient with vitamin C and hydrolyzed hyaluronic acid. The provider positions it around mature-skin appearance, brightness and hydration, and publishes all three headline concentrations.[source]
That helps identify the preparation, but the overall vehicle and prescribed use still matter. A percentage from an ingredient study cannot independently establish the visible result of this exact combination.
The historical study is context, not a product test
A 1996 study compared topical estradiol and estriol preparations in 59 women over six months. It reported changes in several skin measures. It did not test today’s Time Out three-ingredient product.[source]
The distinction leaves room for a clinical rationale without claiming a verified outcome for this formula. FDA states that estriol-containing drugs are not approved, so prescription access should not be described as FDA approval.[source]
Discuss exposure, follow-up and the real charge
CoreAge Rx’s own page acknowledges that topical administration does not necessarily remove systemic absorption. Review hormone-related history, current medicines and the intended application with the prescriber.[source]
The $48 monthly starting point should be checked against the actual amount due, quantity and renewal. Ask how a reaction or new concern will be evaluated after delivery. A moisturizer can be a separate alternative for a person whose main need is simple comfort; age alone does not establish a need for estriol.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- CoreAge Rx: Time OutOfficial source; checked October 8, 2026
- Schmidt et al.: topical estrogens and skin aging1996 study of 59 women comparing two estrogen preparations over six months
- FDA: menopause and hormone questionsNo FDA-approved estriol drugs; compounded does not establish superior safety